comparemela.com

Latest Breaking News On - Biotech and pharma - Page 26 : comparemela.com

Pharma Is Out of Favor 5 Drug Stocks With Room to Grow

Despite Eli Lilly's monster 66.8% gain on the year because of weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.

Bristol myers squibbEli lillyPearl riverArticle normalAgricultural machineryHealthcare life sciencesIndustrial goodsFinancial performanceCorporate industrial newsPolitical general newsPhysical mental fitnessLiving lifestyleWeight managementContent typesFactiva filtersC amp ampe industry news filter

U K Approves Vertex Pharmaceutical and CRISPR s Genetic Scissors Treatment

A Nobel Prize-winning gene editing therapy has been conditionally approved in the U.K., as U.S. regulators near decision.

William blairJosh nathan kazisTim lugoAndrew obenshainWilliam blair lugoSamarth kulkarniDrug administrationVertex pharmaceuticalsNobel prizeArticle normalBiotechnology servicesTrusts funds financial vehiclesPrivate equityScientific research servicesHealthcare life sciencesAlternative investments

Arcellx Stock Surges as Gilead Adds to Stake, Expands Collaboration

The transaction includes cash the smaller biotech can use to develop its business.

Emily dattiloGilead sciencesArticle normalBiotechnology servicesHealthcare life sciencesBiological therapyHealthcare provisionCorporate industrial newsPartnerships collaborationsBiotech and pharmaIndustrial newsLife sciences

Biotech Stocks Are Rallying, but the Outlook Isn t Good

The XBI has been climbing this month. On Tuesday it jumped 5.4% to close at $70.91.

Article normalBiotechnology servicesHousehold institutional street furnitureRetail wholesaleSpecialty retailingTrusts funds financial vehiclesHealthcare life sciencesAuction housesConsumer goodsExchange traded fundsFinancial servicesInvesting securitiesFinancial performanceCorporate industrial newsPolitical general newsSciences humanities

Heart Disease Breakthrough by Gene-Editor Verve Knocks Its Stock for a Loop

Data showed that a single infusion of Verve's genetic treatment led to drops of 40% to 55% in the “bad” LDL cholesterol.

United statesMyles minterDavid liuSekar kathiresanWilliam blairAmerican heart associationDrug administrationRegeneron pharmaceuticalsVerve therapeuticsNobel prize winningEli lillySeamus fernandezBeam therapeuticsBill alpertArticle normalBiotechnology services

vimarsana © 2020. All Rights Reserved.